Prenatal phenotype of PNKP-related primary microcephaly associated with variants affecting both the FHA and phosphatase domain
暂无分享,去创建一个
R. Abou Jamra | H. Rehder | A. Leal | M. Radtke | T. Bartolomaeus | I. Krey | S. Syrbe | B. Popp | C. Roth | D. Le Duc | Luis Bermúdez-Guzmán | J. Döring | K. Schoner | M. Plassmann | Sonja Neuser | A. Schwan | S. Schubert | Stefan Rohde | Alejandro Leal | Tobias Bartolomaeus | Maximilian Radtke | Ilona Krey
[1] H. Rehder,et al. Prenatal phenotype of PNKP-related primary microcephaly associated with variants in the FHA and Phosphatase domain , 2021, medRxiv.
[2] A. Pagnamenta,et al. Clinical, neuroimaging, and molecular spectrum of TECPR2‐associated hereditary sensory and autonomic neuropathy with intellectual disability , 2020, medRxiv.
[3] Y. Matsumoto,et al. Linker region is required for efficient nuclear localization of polynucleotide kinase phosphatase , 2020, PloS one.
[4] A. Leal,et al. Mutational survivorship bias: The case of PNKP , 2020, bioRxiv.
[5] D. Baralle,et al. Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance , 2020, Genetics in Medicine.
[6] U. Schmitz,et al. The changing paradigm of intron retention: regulation, ramifications and recipes , 2019, Nucleic acids research.
[7] C. Pantaleoni,et al. From congenital microcephaly to adult onset cerebellar ataxia: Distinct and overlapping phenotypes in patients with PNKP gene mutations , 2019, American journal of medical genetics. Part A.
[8] A. Angeloni,et al. PNKP deficiency mimicking a benign hereditary chorea: The misleading presentation of a neurodegenerative disorder. , 2019, Parkinsonism & related disorders.
[9] M. Beckmann,et al. Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants , 2019, bioRxiv.
[10] What's happening in Neurology® Genetics , 2019, Neurology.
[11] A. Leal,et al. DNA repair deficiency in neuropathogenesis: when all roads lead to mitochondria , 2019, Translational Neurodegeneration.
[12] A. Kastaniotis,et al. Non-canonical translation initiation in yeast generates a cryptic pool of mitochondrial proteins , 2019, Nucleic acids research.
[13] Tudor Groza,et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources , 2018, Nucleic Acids Res..
[14] Gregory M. Cooper,et al. CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..
[15] A. Ekici,et al. The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy , 2018, bioRxiv.
[16] A. Ekici,et al. The polynucleotide kinase 3′-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25 , 2018, neurogenetics.
[17] Chie Nagata,et al. Diagnostic Accuracy of Ultrasound Scanning for Prenatal Microcephaly in the context of Zika Virus Infection: A Systematic Review and Meta-analysis , 2017, Scientific Reports.
[18] Lindsay E. Burns,et al. Identification of human short introns , 2017, PloS one.
[19] Nathan D. Price,et al. iREAD: a tool for intron retention detection from RNA-seq data , 2017, BMC Genomics.
[20] H. Rehder,et al. Fetal Pathology of Neural Tube Defects – An Overview of 68 Cases Fetalpathologie der Neuralrohrdefekte – ein Überblick über 68 NTD-Fälle , 2017, Geburtshilfe und Frauenheilkunde.
[21] P. Mckinnon,et al. Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease , 2017, Mechanisms of Ageing and Development.
[22] C. Menck,et al. Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease , 2015, Neurology: Genetics.
[23] M. Shimada,et al. Polynucleotide kinase–phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability , 2015, The EMBO journal.
[24] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[25] J. Hardy,et al. Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4 , 2015, American journal of human genetics.
[26] P. Mckinnon. Maintaining genome stability in the nervous system , 2013, Nature Neuroscience.
[27] J. Shendure,et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1 , 2013, Nature Genetics.
[28] H. Stroink,et al. Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations , 2013, neurogenetics.
[29] C. Walsh,et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair , 2010, Nature Genetics.
[30] Laurence H. Pearl,et al. Specific recognition of a multiply phosphorylated motif in the DNA repair scaffold XRCC1 by the FHA domain of human PNK , 2009, Nucleic acids research.
[31] J. Allalunis-Turner,et al. Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination. , 2007, Cancer research.
[32] S. West,et al. Involvement of human polynucleotide kinase in double‐strand break repair by non‐homologous end joining , 2002, The EMBO journal.
[33] A. J. Mcadams. Pathology of the Fetus and Infant , 1963 .
[34] A. Verloes,et al. Microcephaly. , 2013, Handbook of clinical neurology.
[35] K. Nicolaides,et al. Fetal biometry at 14–40 weeks' gestation , 1994, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[36] J. Opitz,et al. Microcephaly: general considerations and aids to nosology. , 1990, Journal of craniofacial genetics and developmental biology.